• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病与帕金森病:系统评价和荟萃分析。

Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses.

机构信息

Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.

Department of Translational Medical Sciences, University of Naples "Federico II", Naples, Italy.

出版信息

J Parkinsons Dis. 2021;11(4):1585-1596. doi: 10.3233/JPD-212725.

DOI:10.3233/JPD-212725
PMID:34486987
Abstract

BACKGROUND

A link between diabetes mellitus (DM) and Parkinson's disease (PD) have been proposed but evidence are sparse and inconsistent.

OBJECTIVE

Perform a systematic review of all evidence that link DM and PD characterising the prevalence of DM in PD patients, the risk of developing PD in DM patients and the influence of DM on PD severity and progression.

METHODS

MEDLINE, Scopus, and Cochrane Library from inception to June 30, 2021 were searched. Studies reporting prevalence, incidence, severity and disease progression of DM and PD were included. Prevalence of DM in PD and incidence of PD in DM patients, and characteristics of PD.

RESULTS

A total of 21 studies (n = 11,396) included data on DM prevalence in PD patients, 12 studies (n = 17,797,221) included data on incidence of PD in DM patients, and 10 studies (n = 2,482) included data on DM impact on PD severity and disease progression. The prevalence of DM in PD patients was 10.02 %, (95%C.I. 7.88 -12.16), DM patients showed a higher risk of developing PD (OR: 1.34 95%CI 1.26-1.43 p < 0.0001) compared to non-DM, and PD patients with DM showed a greater severity of motor symptoms, with higher Hoehn and Yahr stage (SMD: 0.36 95%CI 0.12-0.60; p < 0.001) and higher UPDRS (SMD 0.60 95%CI 0.28-0.92; p < 0.001) compared with PD patients without DM.

CONCLUSION

Although the prevalence of DM in PD patients is similar to the general population, patients with DM have a higher risk of developing PD, and the presence of DM is associated with greater PD severity and faster progression, which suggests that DM may be a facilitating factor of neurodegeneration.

摘要

背景

有人提出糖尿病(DM)和帕金森病(PD)之间存在关联,但证据稀少且不一致。

目的

对所有将 DM 和 PD 联系起来的证据进行系统综述,描述 PD 患者中 DM 的患病率、DM 患者发生 PD 的风险以及 DM 对 PD 严重程度和进展的影响。

方法

检索 MEDLINE、Scopus 和 Cochrane Library 从成立到 2021 年 6 月 30 日的所有内容。纳入报告 DM 和 PD 的患病率、发病率、严重程度和疾病进展的研究。纳入 PD 患者中 DM 的患病率、DM 患者中 PD 的发病率以及 PD 的特征。

结果

共有 21 项研究(n = 11396)纳入了 PD 患者中 DM 患病率的数据,12 项研究(n = 17797221)纳入了 DM 患者中 PD 发病率的数据,10 项研究(n = 2482)纳入了 DM 对 PD 严重程度和疾病进展影响的数据。PD 患者中 DM 的患病率为 10.02%(95%CI 7.88-12.16),DM 患者发生 PD 的风险高于非 DM 患者(OR:1.34,95%CI 1.26-1.43,p < 0.0001),且 PD 合并 DM 的患者运动症状更为严重,Hoehn 和 Yahr 分期更高(SMD:0.36,95%CI 0.12-0.60;p < 0.001),UPDRS 评分更高(SMD 0.60,95%CI 0.28-0.92;p < 0.001)。

结论

尽管 PD 患者中 DM 的患病率与一般人群相似,但 DM 患者发生 PD 的风险更高,且 DM 的存在与 PD 更严重且进展更快相关,这提示 DM 可能是神经退行性变的促进因素。

相似文献

1
Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses.糖尿病与帕金森病:系统评价和荟萃分析。
J Parkinsons Dis. 2021;11(4):1585-1596. doi: 10.3233/JPD-212725.
2
The risk of Parkinson's disease in diabetic people: an updated systematic review and meta-analysis.糖尿病患者患帕金森病的风险:一项最新的系统评价与荟萃分析。
Acta Neurol Belg. 2024 Jun;124(3):775-790. doi: 10.1007/s13760-023-02424-6. Epub 2023 Nov 20.
3
Association between diabetes mellitus and risk of Parkinson's disease: A prisma-compliant meta-analysis.糖尿病与帕金森病风险的关联:一项符合 PRISMA 原则的荟萃分析。
Brain Behav. 2021 Aug;11(8):e02082. doi: 10.1002/brb3.2082. Epub 2021 Jul 21.
4
Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: A systematic review and meta-analysis.糖尿病、糖尿病前期与帕金森病风险、疾病进展之间的关联:一项系统评价与荟萃分析。
Front Aging Neurosci. 2023 Mar 16;15:1109914. doi: 10.3389/fnagi.2023.1109914. eCollection 2023.
5
Effect of diabetes control status on the progression of Parkinson's disease: A prospective study.糖尿病控制状况对帕金森病进展的影响:一项前瞻性研究。
Ann Clin Transl Neurol. 2021 Apr;8(4):887-897. doi: 10.1002/acn3.51343. Epub 2021 Mar 25.
6
Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study.帕金森病非波动型患者的临床问题:一项基于社区的研究。
Mov Disord. 2000 Sep;15(5):826-9. doi: 10.1002/1531-8257(200009)15:5<826::aid-mds1010>3.0.co;2-e.
7
Association of thiazolidinedione with a lower risk of Parkinson's disease in a population with newly-diagnosed diabetes mellitus.噻唑烷二酮类药物与新发糖尿病患者帕金森病风险降低相关。
Ann Med. 2018 Aug;50(5):430-436. doi: 10.1080/07853890.2018.1488083. Epub 2018 Jul 21.
8
Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.糖尿病与帕金森病中更严重的认知障碍独立相关。
Parkinsonism Relat Disord. 2014 Dec;20(12):1394-8. doi: 10.1016/j.parkreldis.2014.10.008. Epub 2014 Oct 15.
9
H. pylori and Parkinson's disease: Meta-analyses including clinical severity.幽门螺杆菌与帕金森病:包括临床严重程度的荟萃分析。
Clin Neurol Neurosurg. 2018 Dec;175:16-24. doi: 10.1016/j.clineuro.2018.09.039. Epub 2018 Oct 1.
10
Diabetes Mellitus is Associated with a Higher Relative Risk for Parkinson's Disease in Women than in Men.糖尿病与女性帕金森病的相对风险比男性更高。
J Parkinsons Dis. 2021;11(2):793-800. doi: 10.3233/JPD-202486.

引用本文的文献

1
Gut microbial production of imidazole propionate drives Parkinson's pathologies.肠道微生物产生的咪唑丙酸会引发帕金森病病理变化。
Nat Commun. 2025 Sep 5;16(1):8216. doi: 10.1038/s41467-025-63473-4.
2
Dopamine D2 receptor modulation of insulin receptor signaling in the central amygdala: implications for compulsive-like eating behavior.多巴胺D2受体对中央杏仁核中胰岛素受体信号传导的调节:对强迫性进食行为的影响。
Mol Psychiatry. 2025 Aug 30. doi: 10.1038/s41380-025-03150-6.
3
Targeting glucose transporters in parkinson's disease: a novel metabolic approach for disease modification.
靶向帕金森病中的葡萄糖转运体:一种用于疾病修饰的新型代谢方法。
Metab Brain Dis. 2025 Aug 29;40(7):253. doi: 10.1007/s11011-025-01697-5.
4
GLP-1 receptor agonists in Parkinson's disease: an updated comprehensive systematic review with meta-analysis.胰高血糖素样肽-1受体激动剂在帕金森病中的应用:一项更新的综合系统评价及荟萃分析
Diabetol Metab Syndr. 2025 Aug 23;17(1):352. doi: 10.1186/s13098-025-01888-1.
5
Unraveling α-synuclein and amylin co-aggregation: pathological insights and biomarker development for Parkinson's disease.解析α-突触核蛋白与胰岛淀粉样多肽的共聚集:帕金森病的病理学见解与生物标志物开发
Theranostics. 2025 Jun 20;15(15):7409-7424. doi: 10.7150/thno.112396. eCollection 2025.
6
The role of diabetes mellitus on delirium onset: a systematic review and meta-analysis.糖尿病在谵妄发作中的作用:一项系统评价和荟萃分析。
Cardiovasc Diabetol. 2025 May 19;24(1):216. doi: 10.1186/s12933-025-02782-w.
7
Hematological and biochemical markers and cytokine levels in hospitalized psychiatric patients with COVID-19.新冠病毒病住院精神科患者的血液学和生化标志物及细胞因子水平
Front Immunol. 2025 Apr 11;16:1536117. doi: 10.3389/fimmu.2025.1536117. eCollection 2025.
8
Metabolomics in Parkinson's Disease and Correlation with Disease State.帕金森病中的代谢组学及其与疾病状态的相关性
Metabolites. 2025 Mar 18;15(3):208. doi: 10.3390/metabo15030208.
9
Suicide Risk and Associated Factors in Parkinson Disease: A Nationwide Cohort Study.帕金森病的自杀风险及相关因素:一项全国性队列研究。
Eur J Neurol. 2025 Mar;32(3):e70111. doi: 10.1111/ene.70111.
10
Optic Disc Pallor in Parkinson's Disease: A UK Biobank Study.帕金森病中的视盘苍白:一项英国生物银行研究。
Mov Disord. 2025 Jun;40(6):1123-1133. doi: 10.1002/mds.30127. Epub 2025 Jan 30.